Riccobene Todd A - US Med Affairs Res & Dev, AbbVie Inc

基本信息

浏览量：24

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 49 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Dalbavancin Utilization Registry Investigating Value and Effectiveness (DRIVE): Outcomes Report on Real-World Use

Bruce M. Jones,Kerry O. Cleveland,Pedro L. Gonzalez,Urania Rappo,Todd Riccobene,Rosie D. Lyles

Clinical Infection in Practice (2024): 100251-100251

引用0浏览0引用

Dose Selection for Aztreonam-Avibactam, Including Adjustments for Renal Impairment, for Phase IIa and Phase III Evaluation

Shampa Das,Todd Riccobene,Timothy J. Carrothers,James G. Wright,Merran MacPherson,Andrew Cristinacce,Lynn McFadyen, Rujia Xie,Alison Luckey,Susan Raber

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGYno. 4 (2024): 529-543

引用0浏览0WOS引用

Outcomes of Inadequate Empiric Therapy and Timing of Newer Antibacterial Therapy in Hospitalized Adults with Culture-Positive Enterobacterales and Pseudomonas Aeruginosa: a Multicenter Analysis

Todd Riccobene,Gang Ye,John Lock,Kalvin C. Yu,ChinEn Ai, Sara Gregory,Vikas Gupta

BMC INFECTIOUS DISEASES（2024）

引用0浏览0WOS引用

Real-world Utilization of Ceftazidime/avibactam among Inpatients in the National Veterans Affairs Healthcare System

Aisling R. Caffrey,Haley J. Appaneal,Vrishali V. Lopes,Todd A. Riccobene,Kerry L. Laplante

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACYno. 12 (2024): 509-520

引用0浏览0WOS引用

Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings

Frank Lovecchio,Matthew W. Mccarthy,Xiaolan Ye, Alasdair D. Henry,Quan Doan,John L. Lock,Todd Riccobene,Rosie D. Lyles,David A. Talan

JOURNAL OF EMERGENCY MEDICINEno. 2 (2024): e217-e229

引用0浏览0WOS引用

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients with Acute Bacterial Skin and Skin Structure Infections

Manana Giorgobiani,Margaret H. Burroughs,Tinatin Antadze,Timothy J. Carrothers,Todd A. Riccobene,Rinal Patel, Tao Lin,Penka Stefanova

PEDIATRIC INFECTIOUS DISEASE JOURNAL（2023）

引用2浏览0WOS引用

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients with Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials

Todd Riccobene,John Lock,Rosie D. Lyles,Benjamin Georgiades, Michael Nowak,Pedro L. Gonzalez,Jenny Park,Urania Rappo

Open Forum Infectious Diseases（2023）

引用0浏览0WOS引用

2166. Real-world Susceptibilities to Newer Antibiotics in Enterobacterales and Pseudomonas Aeruginosa Including Carbapenem Non-Susceptible and Multi-Drug Resistant Isolates : A Multicenter Analysis

Todd Riccobene,ChinEn Ai,Kalvin Yu, Simon Gregory, Brooke Kim,Dmitri Debabov,Vikas Gupta

Open forum infectious diseasesno. Supplement_2 (2023)

引用0浏览0引用

Population Pharmacokinetic Modeling for Ceftazidime‐Avibactam Renal Dose Adjustments in Pediatric Patients 3 Months and Older

Richard Franzese,Todd Riccobene,Timothy Carrothers,Manoli Vourvahis,Erica Winter,Mark Lovern,Lynn McFadyen

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 1 (2023): 182-195

引用1浏览0WOS引用

1931. Real-world Evaluation of Adequacy of Empiric and Definitive Therapy in Carbapenem Susceptible and Non-Susceptible Enterobacterales and Pseudomonas Aeruginosa by Time to Culture Result: A Multicenter Analysis

Todd Riccobene,ChinEn Ai,Kalvin Yu, Simon Gregory,John Lock, Brooke Kim,Vikas Gupta

Open forum infectious diseasesno. Supplement_2 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn